Medical Developments International Ltd
ASX:MVP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medical Developments International Ltd
ASX:MVP
|
AU |
|
C
|
Cerro De Pasco Resources Inc
CNSX:CDPR
|
CA |
|
Kaspien Holdings Inc
F:TWDA
|
US |
|
Paysign Inc
NASDAQ:PAYS
|
US |
|
Hong Kong Technology Venture Co Ltd
HKEX:1137
|
HK |
|
Yangarra Resources Ltd
TSX:YGR
|
CA |
|
PSC Insurance Group Ltd
ASX:PSI
|
AU |
|
Surgical Science Sweden AB
OTC:SUSRF
|
SE |
|
Inmode Ltd
NASDAQ:INMD
|
IL |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Jagran Prakashan Ltd
NSE:JAGRAN
|
IN |
|
National Gas and Industrialization Company SJSC
SAU:2080
|
SA |
|
A
|
Adobe Inc
BMV:ADBE
|
US |
|
Empresaria Group PLC
LSE:EMR
|
UK |
|
P
|
Philex Mining Corp
XPHS:PX
|
PH |
|
Xtra Gold Resources Corp
TSX:XTG
|
BS |
Wall Street
Price Targets
MVP Price Targets Summary
Medical Developments International Ltd
According to Wall Street analysts, the average 1-year price target for
MVP
is 0.87 AUD
with a low forecast of 0.86 AUD and a high forecast of 0.89 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MVP's stock price target?
Price Target
0.87
AUD
According to Wall Street analysts, the average 1-year price target for
MVP
is 0.87 AUD
with a low forecast of 0.86 AUD and a high forecast of 0.89 AUD.
What is Medical Developments International Ltd's Revenue forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Medical Developments International Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
11%.
What is Medical Developments International Ltd's Net Income forecast?
Projected CAGR
194%
For the last 13 years the
compound annual growth rate for
Medical Developments International Ltd's net income is
-23%.
The projected
CAGR
for the next 3 years is
194%.
